Gore RELINE MAX Clinical Study Outcomes
Explore durability with principal investigator Peter Soukas, M.D., as he details 3-year outcomes in real-world superficial femoral artery in-stent restenosis lesions treated with the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface*.
As used by Gore, Heparin Bioactive Surface refers to Gore's proprietary CBAS® Heparin Surface.
Learn more: https://www.goremedical.com/products/...
YouTube is a global platform, and Gore is not able to restrict certain audiences. This video is intended only for a medical professional audience in the following countries and/or regions: United States. It contains information on devices that have been cleared, approved, or authorized by applicable regulators in those countries/regions.